Persian Medicine Products in Covid-19

INTERVENTION: Intervention 1: Intervention group: In the intervention group, in addition to the standard treatment, medicinal herbal products will be prescribed. The drug will be given in two combination forms. One in the form of a syrup containing the following medicinal herbs: Zattaria multiflora, Punicagranatum, Marticaria chamomilla, Zizyphus sativa and Mentha spp, and the other in the form of a capsule containing the following medicinal herbs: Rheum officinale, nigella Sativa andnepeta bracteata . In addition to the usual treatment, the intervention group, will receive a capsule every 8 hours and 10 cc of of Iranian medicine syrup every 8 hours for one week. The capsule will be taken at least half an hour after taking the syrup. Intervention 2: Control group: Get standard treatment. CONDITION: Covid‐19. ; Covid‐19 RA01.0 PRIMARY OUTCOME: Oxygen saturation. Timepoint: Clinical examination and Pulse Oximetry before starting medication and regularly during treatment. Method of measurement: Pulse Oximeter. Respiratory Rate. Timepoint: Clinical examination before starting medication and regularly during treatment. Method of measurement: respiratory Count. SECONDARY OUTCOME: C‐reactive protein. Timepoint: Intravenous blood testing before starting medication and during treatment. Method of measurement: Intravenous blood test. Lymphocytes. Timepoint: Intravenous blood testing before starting medication and during treatment. Method of measurement: Intravenous blood test. White Blood Cells. Timepoint: Intravenous blood testing before starting medication and during treatment. Method of measurement: Intravenous blood test. INCLUSION CRITERIA: Over 18 years old patients hospitalized, with or suspected of COVID‐19